M Aladdin Bhuiyan (Aladdin M Bhuiyan)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Regulatory T Cells

Oxidative Stress

Top Venues

Science translational medicine

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Kevin Roehle, Li Qiang, Katherine S Ventre, Daniel Heid, Lestat R Ali, Patrick J Lenehan, Max Heckler, Stephanie J Crowley, Courtney T S Kureshi, Gabrielle Ro, Anže Godicelj, M Aladdin Bhuiyan, Annan Yang, Maria Quiles Del Rey, Tamara Biary, Adrienne M Luoma, Patrick T Bruck, Jana F Tegethoff, Svenja L Nopper, Jinyang Li, Katelyn T Byrne, Marc Pelletier, Kai W Wucherpfennig, Ben Z Stanger, James J Akin, Joseph D Mancias, Judith Agudo, Michael Dougan, Stephanie K Dougan
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes. Science translational medicine 13 (594) (2021)
Ricardo A Fernandes, Leon L Su, Yoko Nishiga, Junming Ren, M Aladdin Bhuiyan, Ning Cheng, Calvin J Kuo, Lora K Picton, Shozo Ohtsuki, Robbie G Majzner, Skyler P Rietberg, Crystal L Mackall, Qian Yin, Lestat R Ali, Xinbo Yang, Christina S Savvides, Julien Sage, Michael Dougan, K Christopher Garcia
Immune receptor inhibition through enforced phosphatase recruitment. Nature 586 (7831) (2020)
Eleanor Clancy-Thompson, Christine A Devlin, Paul M Tyler, Mariah M Servos, Lestat R Ali, Katherine S Ventre, M Aladdin Bhuiyan, Patrick T Bruck, Michael E Birnbaum, Stephanie K Dougan
Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer immunology research 6 (12) (2018)